Animal Drugs Market Research Report Analysis and Forecasts to 2027

 Elanco Animal Health, Ceva Sante Animale, Boehringer Ingelheim International GmbH, Dechra Pharmaceuticals Ltd, and Virbac S.A., are some other renowned animal drug industry players.

Significantly impelled by the burgeoning emphasis on good health and well-being, the consumption of animal drugs will soar in the coming years. The surging obligation for preventing, controlling, diagnosing and curing diseases that affect the health of domestic as well as wild animals along with their transmission to humans has stirred the rapid advancements in veterinary medicine.

To access a sample copy or view the market report in detail along with the table of

contents, please click the link below:  https://www.gminsights.com/request-sample/detail/4445

Animals, these days, are largely domesticated and produce major food items, thus their health is indirectly related to that of humans. There has also been a considerable rise in the pet population worldwide. According to the American Veterinary Medical Association (AVMA), over 57% of homes in the U.S. have at least one pet. In light of these factors, farmers and pet owners are actively turning to animal drugs and care to keep the animals healthy and disease-free.

Taking a note of this, several veterinary medicine companies are placing targeted efforts on new drug formulations and delivery to meet the escalating livestock and companion animal requirements. For instance, in February 2022, Merck Animal Health inked a four-year strategic alliance with Iowa State University for addressing complex needs and expediting the delivery of animal health solutions to the marketplace. The increasing focus on ensuring good health and essential nutrition while keeping up the production of goods from animals will further sway the market development.

It has therefore been reported that the global animal drugs market size will surpass USD 46 billion in valuation by 2027.

Browse key industry insights spread across 285 pages with 567 market data tables & 18 figures & charts from the report, “Animal Drugs Market Size By Product (Drugs {Antiparasitic, Anti-inflammatory, Anti-infectives}, Vaccines {Modified Live Vaccines [MLV], Killed Inactivated Vaccines}, Medicated Feed Additives {Antibiotics, Vitamins, Amino Acids, Enzymes, Antioxidants, Prebiotics and Probiotics, Minerals}, By Animal Type (Livestock Animals {Poultry, Swine, Cattle, Fish}, Companion Animals {Dogs, Cats, Horses}), By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacy and Drug Stores, E-commerce), COVID-19 Impact Analysis, Regional Outlook, Application Development Potential, Competitive Market Share & Forecast, 2021 – 2027” in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/animal-drugs-market

Increasing demand for vaccines

Vaccines are expected to bring significant gains for the animal drugs market in the coming years, driven by higher burden of animal-transmitted diseases like rabies, parvovirus, and E. coli. The WHO (World Health Organization) has estimated that rabies causes over 59 000 human deaths per year in over 150 countries, with over 95% of cases in Africa and Asia. Hence, vaccines are timely inoculated for keeping the animals healthy and reducing suffering & losses, in turn protecting the public well-being.

The emergence of novel vaccines, including mRNA and other delivery methods for preventing diseases while protecting more animals, notably in the current COVID-19 outbreak will additionally drive the expansion of the overall industry. For instance, in July 2020, Merck announced its plans of injecting $100 million into its Kansas manufacturing site to ramp up its vaccine production.

Rising scope in poultry industry

Penetration of animal drugs may show a potential rise in livestock on account of the thriving need for antimicrobial resistance. As meat and dairy products are massively consumed across most parts of the world, it is crucial to look after the food and nutritional wellbeing of domesticated animals. It has been reported that poultry consumption in China accounted for 20 million tons in 2019.

Antibiotics are also increasingly included in animal feeds and are utilized in the treatment of sick animals. The dearth of trained veterinarians, along with higher disease challenges, specifically in Africa will anchor the industry development.

 

Aside from boosting the production of farm supplies and minimizing the negative effects of animals on people’s health, drugs and vaccines ensure the safety of animal products, like milk, meat and eggs. The escalating regulatory and funding support for monitoring drug use will infuse a positive outlook for the animal drugs industry growth.

Partial Table of Contents (ToC) of the report:

Chapter 1   Methodology

1.1    Market definition

1.2    Base estimates & working

1.3    Forecast parameters

1.4    Data validation

1.5    Data sources

1.5.1    Secondary

1.5.1.1    Paid sources

1.5.1.2    Unpaid sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    Animal drugs industry 3600 synopsis, 2016 - 2027

2.1.1    Business trends

2.1.2    Product trends

2.1.3    Animal type trends

2.1.4    Route of administration trends

2.1.5    Distribution channel trends

2.1.6    Regional trends

Browse complete table of content of this report@  https://www.gminsights.com/industry-analysis/animal-drugs-market

About Global Market Insights

Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone:1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com 
Web: https://www.gminsights.com/industry-reports/healthcare-and-medical-devices